Business Kuopio


A unique healthcare industry ecosystem

Kuopio offers companies in the health sector a unique industry ecosystem that stimulates innovation, supports research and development, and offers access to experts and talents to bolster business success.

Kuopio’s global leadership in health and life sciences is driving innovation in specialist areas such as Metabolic, Heart, Cardiovascular, and Neurological diseases, including Alzheimer’s and Parkinson’s. The ecosystem benefits greatly from Big Data sources via the region’s university hospital’s data lakes and through secondary use of health data through Sensors, Robotics, and Internet of Things. Due to robust research and knowhow, Kuopio is considered a part of the main Health Science hub in Finland.

Neurocenter Finland, which has its headquarters in Kuopio, is a one-stop shop for research in neurosciences and product development in Finland, involving the entire spectrum of neuroscience knowhow. It facilitates innovations and the development of new personalized healthcare. In addition, VTT has launched new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The aim is to create state-of-the-art research based especially on the utilisation of health data, generate new digital health innovations and establish global health technology business in Finland and the Kuopio region.

Other strong actors in Kuopio health industry include GE Healthcare, Charles River, and FinVector.

At the heart of our health sciences cluster is the KuopioHealth open innovation ecosystem, which is an innovation alliance between the University of Eastern Finland, Kuopio University Hospital, Savonia University of Applied Sciences and City of Kuopio, with tens of industrial partners. It is fast becoming one of the world’s leading open innovation ecosystems.

The health science cluster is divided into three main research and development areas:



Valuable partners for pharmaceutical development


Fastest growing med-tech innovation ecosystem

Clinical Research

To a better understanding of treatment and the development of new therapies

Mikael von und zu Fraunberg, Director, Neurocenter Finland
Mikael von und zu Fraunberg, Director, Neurocenter Finland

“Critical mass of researchers and university hospital was important factor in the placement of Neurocenter. But it is not enough to have world class research. There must also be communal support and ecosystems. The city of Kuopio has seen the potential of the Neurocenter and their support for creating an ecosystem has been very important for our success.”